Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Double-Blind Method. Found 10 abstracts

Golan T, Hammel P, Reni M, Van Cutsem E, Macarulla T, Hall MJ, Park JO, Hochhauser D, Arnold D, Oh DY, Reinacher-Schick A, Tortora G, Algul H, O'Reilly EM, McGuinness D, Cui KY, Schlienger K, Locker GY, Kindler HL. Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer. The New England journal of medicine. 2019 Jul 25;381(4):317-27.   PMCID: PMC6810605
Edelman MJ, Wang X, Hodgson L, Cheney RT, Baggstrom MQ, Thomas SP, Gajra A, Bertino E, Reckamp KL, Molina J, Schiller JH, Mitchell-Richards K, Friedman PN, Ritter J, Milne G, Hahn OM, Stinchcombe TE, Vokes EE. Phase III Randomized, placebo-controlled, double-blind trial of celecoxib in addition to standard chemotherapy for advanced non-small-cell lung cancer with cyclooxygenase-2 overexpression: CALGB 30801 (Alliance). Journal of Clinical Oncology. 2017 Jul;35(19):2184-92.   PMCID: PMC5493050
Fan F, Yuan Z, Qin X, Li J, Zhang Y, Li Y, Yu T, Ji M, Ge J, Zheng M, Yang X, Bao H, Cheng X, Gu D, Zhao D, Wang J, Sun N, Chen Y, Wang H, Wang X, Parati G, Hou F, Xu X, Wang X, Zhao G, Huo Y. Optimal Systolic Blood Pressure Levels for Primary Prevention of Stroke in General Hypertensive Adults: Findings From the CSPPT (China Stroke Primary Prevention Trial). Hypertension (Dallas, Tex : 1979). 2017 Apr;69(4):697-704.
Haas NB, Manola J, Dutcher JP, Flaherty KT, Uzzo RG, Atkins MB, DiPaola RS, Choueiri TK. Adjuvant Treatment for High-Risk Clear Cell Renal Cancer: Updated Results of a High-Risk Subset of the ASSURE Randomized Trial. JAMA Oncol. 2017 Sep;3(9):1249-52.   PMCID: PMC5591751
Qin X, Li Y, Sun N, Wang H, Zhang Y, Wang J, Li J, Xu X, Liang M, Nie J, Wang B, Cheng X, Li N, Sun Y, Zhao L, Wang X, Hou FF, Huo Y. Elevated Homocysteine Concentrations Decrease the Antihypertensive Effect of Angiotensin-Converting Enzyme Inhibitors in Hypertensive Patients. Arteriosclerosis, thrombosis, and vascular biology. 2017 Jan;37(1):166-72.
Haas NB, Manola J, Uzzo RG, Flaherty KT, Wood CG, Kane C, Jewett M, Dutcher JP, Atkins MB, Pins M, Wilding G, Cella D, Wagner L, Matin S, Kuzel TM, Sexton WJ, Wong YN, Choueiri TK, Pili R, Puzanov I, Kohli M, Stadler W, Carducci M, Coomes R, DiPaola RS. Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial. Lancet (London, England). 2016 May 14;387(10032):2008-16.   PMCID: PMC4878938
Burger RA, Brady MF, Bookman MA, Monk BJ, Walker JL, Homesley HD, Fowler J, Greer BE, Boente M, Fleming GF, Lim PC, Rubin SC, Katsumata N, Liang SX. Risk factors for GI adverse events in a phase III randomized trial of bevacizumab in first-line therapy of advanced ovarian cancer: A Gynecologic Oncology Group Study. J Clin Oncol. 2014 Apr 20;32(12):1210-7.   PMCID: Pmc3986384
Pisansky TM, Pugh SL, Greenberg RE, Pervez N, Reed DR, Rosenthal SA, Mowat RB, Raben A, Buyyounouski MK, Kachnic LA, Bruner DW. Tadalafil for prevention of erectile dysfunction after radiotherapy for prostate cancer: the Radiation Therapy Oncology Group [0831] randomized clinical trial. Jama. 2014 Apr 02;311(13):1300-7.   PMCID: 4669050
Cristofanilli M, Valero V, Mangalik A, Royce M, Rabinowitz I, Arena FP, Kroener JF, Curcio E, Watkins C, Bacus S, Cora EM, Anderson E, Magill PJ. Phase II, randomized trial to compare anastrozole combined with gefitinib or placebo in postmenopausal women with hormone receptor-positive metastatic breast cancer. Clinical Cancer Research. 2010 Mar 15;16(6):1904-14.   PMCID: NIHMS352308
Martinez E, Tatum KL, Weber DM, Kuzla N, Pendley A, Campbell K, Ridge JA, Langer C, Miyamoto C, Schnoll RA. Issues related to implementing a smoking cessation clinical trial for cancer patients. Cancer causes & control : CCC. 2009 Feb;20(1):97-104.   PMCID: PMC2628415
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Double-Blind Method

Middle Aged Double-Blind Method Female Aged Male drug therapy therapeutic use Treatment Outcome administration & dosage 80 and over Aged pathology Survival Rate Disease-Free Survival Adult Antineoplastic Agents Neoplasm Staging adverse effects Risk Factors Hypertension Phenylurea Compounds secondary mortality prevention & control Indoles Blood Pressure Enalapril Follow-Up Studies Pyrroles Time Factors etiology analogs & derivatives drug effects Neoplasm Metastasis complications physiopathology Oral Administration hypertension Renal Cell Carcinoma Kidney Neoplasms Niacinamide Antineoplastic Combined Chemotherapy Protocols metabolism Folic Acid Adjuvant Chemotherapy China Angiotensin-Converting Enzyme Inhibitors epidemiology Prospective Studies genetics Smoking Cessation Primary Prevention biosynthesis Logistic Models physiology homocysteine concentrations Psychological Adaptation Progression-Free Survival goal blood pressure Maintenance Chemotherapy folic acid therapy enalapril-based antihypertensive treatment methods Epidermal Growth Factor Receptor surgery Neoplasms Drug Dose-Response Relationship Adenocarcinoma Piperazines Tissue Distribution Organoplatinum Compounds Germ-Line Mutation Phthalazines trends erbB-2 Receptor Combination Drug Therapy antihypertensive responses primary prevention Breast Neoplasms Quinazolines Erectile Dysfunction pharmacokinetics Health Promotion Hormone-Dependent Neoplasms Marriage Triazoles Kaplan-Meier Estimate Ovarian Neoplasms Pemetrexed Homocysteine Cyclooxygenase 2 Inhibitors stroke BRCA2 Genes Postmenopause Sorafenib radiotherapy Up-Regulation Estrogen Receptors Lung Neoplasms Sexual Behavior Stroke BRCA1 Genes Monoclonal Antibodies-Humanized Lymphatic Metastasis Biomarkers Carboplatin Antineoplastic Combined Chemotherapy blood Radiation Injuries Antihypertensive Agents Vitamin B Complex Pancreatic Neoplasms Taxoids Gastrointestinal Diseases Incidence chemically induced Small Cell Carcinoma Dinoprostone urine Carbolines Young Adult Prostatic Neoplasms Protocols general hypertensives enzymology Patient Satisfaction Cyclooxygenase 2 Sunitinib Drug Administration Schedule Progesterone Receptors Celecoxib therapy Brachytherapy Vasodilator Agents Nitriles
Last updated on Sunday, July 12, 2020